Europe may be interested in Ukraine supplying raw materials for medicine production – Health Ministry
Europe may be interested in Ukraine supplying raw materials for the production of medicines, believes Deputy Minister of Health Edem Adamanov.
"What are Europeans most interested in? Currently, they are most interested not even in finished products, but in APIs (active pharmaceutical ingredients) – these are raw materials for the production of medicines. And they would very much like the production of APIs to be closer to them," he said in an interview with Interfax-Ukraine.
Adamanov noted that European pharmaceutical companies depend on Asian countries, since 99% of APIs are manufactured there.
"Producing APIs within the EU is super expensive. Europeans are much more interested in developing API production in Ukraine. Of course, one of the largest API producers in the world is, for example, India, but Ukraine is closer to Europe," he emphasized.
Advertising
Advertising
MORE ABOUT
European Council, European Parliament agree on plan to end Russian gas imports
09:05, 03.12.2025
Ukraine preparing agreements with European nations to strengthen air protection – Zelenskyy
20:35, 10.11.2025
Romanian Defense Ministry confirms reduction in US troop numbers in Europe
13:19, 29.10.2025
CoE Secretary General shocked by death of journalist, cameraman from Freedom TV channel due to Russian drone strike
20:53, 23.10.2025
Zelenskyy announces new defense capabilities agreement with European partners
19:21, 21.10.2025
LATEST
Polish court issues European arrest warrants for Ukrainians suspected of railway sabotage
20:54, 04.12.2025
Eight people injured in Kherson region amid Russian shelling - prosecutor's office
20:42, 04.12.2025
Turkish MFA summons reps of Ukrainian and Russian diplomatic missions ‘due to spread of war in Black Sea’ – media
20:22, 04.12.2025
19 Ukrainian sites added to UNESCO's Intl List of Cultural Property
20:07, 04.12.2025
Germany announces EUR 100 mln to Energy Support Fund, increasing its contribution to EUR 550 mln